Identification of CD105 (endoglin) as novel risk marker in CLL

Several genetic and clinical markers are established as prognostic factors in chronic lymphocytic leukemia (CLL). However, additional markers are needed for risk stratification. Flow cytometric analysis is a mainstay of CLL diagnostics, thus identification of novel prognostic surface markers can imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Greiner, Sarah M., Märklin, Melanie, Holzmayer, Samuel, Kaban, Kübra, Meyer, Sophie, Hinterleitner, Clemens, Tandler, Claudia, Hagelstein, Ilona, Jung, Gundram, Salih, Helmut R., Heitmann, Jonas S., Kauer, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913466/
https://www.ncbi.nlm.nih.gov/pubmed/35044512
http://dx.doi.org/10.1007/s00277-022-04756-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913466/
https://www.ncbi.nlm.nih.gov/pubmed/35044512
http://dx.doi.org/10.1007/s00277-022-04756-4

Ejemplares similares